We partner with dreamers to transform their most audacious scientific research into clinical breakthroughs. Positioned at the nexus of academia and industry, our pH Fellowship serves as a critical translational bridge between these two worlds, offering fellows $200,000 in equity financing, expert guidance, end-to-end oversight of all licensing and IP negotiations, and access to future funding.
Together, we'll redefine healthcare in the 21st century and develop the next generation of therapeutics and biotechnologies to both cure the deadliest age-related diseases and extend human healthspan.
Cohort 1 is now open.